Evan Edwards Kymanox

Evan Edwards is President at Kymanox where he supports overall business strategy and growth, as well as oversees the Quality, Human Factors and Regulatory Strategy teams. Evan is also an Executive Advisor for the Company and provides strategic support for Sponsors as an expert in drug/device combination product development. Prior to Kymanox, Evan was Co-Founder and Vice-President of Innovation, Development & Industrialization at kaléo Inc., a pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. He is coinventor of the kaleo’s drug delivery platforms including epinephrine auto-injectors Auvi-Q® and Allerject® (in Canada) as well as EVZIO (naloxone HCL injection) AutoInjector.